A coalition of companies is participating in what is expected to be Europe's first clinical trial to be conducted remotely in full. The study is of a newly CE-marked blood glucose monitor from Finnish company Mendor.
Johnson & Johnson has crafted three new research platforms designed to help its teams of investigators focus on a set of key strategic disease initiatives that will help guide their multibillion-dollar drug development program. And J&J--which is adding an institute for microbiome R&D along with a pioneering effort to prevent Type 1 diabetes in the ramp-up--plans to use their central position in the research structure to help coordinate in-house work with their growing cast of development partners around the world.
Vaxxas announced Monday that it raised $20 million in a Series B round, which will be used to advance a series of clinical programs and to develop a pipeline of new vaccine products using the company's needle-free Nanopatch platform.
As scientists race to uncover ways to diagnose neurogenerative diseases in patients, Danish researchers have pinpointed a new biomarker that could predict an individual's risk of for dementia through a blood test.
The National Center for Complementary and Integrative Health at the National Institutes of Health (NIH) has proposed conducting large research studies of nondrug pain management approaches. It did so in a report by a working group of the Center's Advisory Council.
Alzheimer's, depression, Parkinson's and the rest of the neuroscience targets of interest in biopharma have created a disaster zone for R&D teams in recent years. That's why AstraZeneca, GlaxoSmithKline and others have either pulled way back or completely out of the field. But in their wake, you can now detect a new generation of small biotechs stepping up with promising programs to revolutionize the field.
Researchers at the University of North Carolina, Chapel Hill, have used electrical fields to deliver chemotherapy drugs to difficult tumors, and the small electrical charges have shown in animal tests to drive the therapies deep into solid tumors that were once hard to reach.
A team of scientists from Singapore's Nanyang Technological University and the Singapore Eye Research Institute is developing an injectable eye medication that utilizes extended-release nanoparticles to treat glaucoma, or fluid buildup in the eye that can lead to blindness.
In the wake of a report that found serious errors in what was considered breakthrough work in stem cells, Japan's Riken Institute has fired the lead researcher retroactively and is considering criminal charges.
St. Jude Medical is starting a trial for a device that it hopes will be the smallest FDA-approved pediatric mechanical heart valve. The device is only 15 mm in diameter; that's roughly equivalent to the length of a staple.